[1] Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291(23):2865-8.
[2] Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386(9988):85-96.
[3] Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guideline for the management of acute pancreatitis. Pancreatology. 2013;13:e1-15.
[4] Shinzeki M, Ueda T, Takeyama Y, Yasuda T, Matsumura N, Sawa H, et al. Prediction of early death in severe acute pancreatitis. J Gastroenterol. 2008;43(2):152-8.
[5] Zhou MT, Chen CS, Chen BC, Zhang QY, Andersson R. Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol. 2010;16(17):2094-9.
[6] Akbarshahi H, Rosendahl AH, Westergren-Thorsson G, Andersson R. Acute lung injury in acute pancreatitis--awaiting the big leap. Respir Med. 2012;106(9):1199-210.
[7] Luan ZG, Zhang XJ, Yin XH, Ma XC, Zhang H, Zhang C, et al. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis. Immunobiology. 2013;218(10):1261-70.
[8] Zyromski N, Murr MM. Evolving concepts in the pathophysiology of acute pancreatitis. Surgery. 2003;133(3):235-7.
[9] Anand N, Park JH, Wu BU. Modern management of acute pancreatitis. Gastroenterol Clin North Am. 2012;41(1) :1-8.
[10] Elder AS, Saccone GT, Dixon DL. Lung injury in acute pancreatitis: mechanisms underlying augmented secondary injury. Pancreatology. 2012;12(1):49-56.
[11] Zhou Q, Sun Y, Tan W, Liu X, Qian Y, Ma X, et al. Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats. PLoS One. 2017;12(4):e0176777.
[12] Xian S, Yang Z, Lee J, Jiang Z, Ye X, Luo L, et al. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure. J Ethnopharmacol. 2016;186:136-142.
[13] Yu YH, Cui NQ, Fu Q, Li J. Change of TH1/TH2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection. Chin J Integr Med. 2005;11(2):136-41.
[14] Yao N, Chen N, Xu X, Sun D, Liu W, Li G, et al. Protective effect of Shenmai injection on knee articular cartilage of osteoarthritic rabbits and IL-1β-stimulated human chondrocytes. Exp Ther Med. 2017;13(6):3013-3020.
[15] Zhao L, Wu J, Zhang X, Kuang H, Guo Y, Ma L. The effect of Shenmai injection on the proliferation of Rat airway smooth muscle cells in asthma and underlying mechanism. BMC Complement Altern Med. 2013;13:221.
[16] Lu LY, Zheng GQ, Wang Y. An overview of systematic of reviews of shenmai injection for healthcare. Evid Based Complement Alternat Med. 2014;2014:840650.
[17] Yu J, Xin YF, Gu LQ, Gao HY, Xia LJ, You ZQ, et al. One-month toxicokinetic study of SHENMAI injection in rats. J Ethnopharmacol. 2014;154(2):391-9.
[18] Wei YL, Li YJ, Liu X. Experimental study of protective effect of shenmai injection on endotoxin induced systemic inflammatory reaction syndrome and multiple organ dysfunction syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21(1):47-50.
[19] Wang JL, Chen Y, Song XQ, Lu ML, Zhao B, Ma L, et al. Biliary tract external drainage protects against multiple organs injuries of severe acute pancreatitis rats via heme oxygenase-1 upregulation. Pancreatology. 2017;17(2):219-227.
[20] Zhang FH, Sun YH, Fan KL, Dong XB, Han N, Zhao H, et al. Protective effect of heme oxygenase-1 against severe acute pancreatitis via inhibition of tumor necrosis factor-α and augmentation of interleukin-10. BMC Gastroenterol. 2017;17(1):100.
[21] Zhao B, Fei J, Chen Y, Ying YL, Ma L, Song XQ, et al. Vitamin C treatment attenuates hemorrhagic shock related multi-organ injuries through the induction of heme oxygenase-1. BMC Complement Altern Med. 2014;14:442.
[22] Mehaffey JH, Chaeles EJ, Schubert S, Salmon M, Sharma AK, Money D, et al. In vivo lung perfusion rehabilitates sepsis-induced lung injury. J Thorac Cardiovasc Surg. 2018;155(1):440-448.
[23] Oliva J, Mustonen H, Kylanpaa ML, Kyhala K, Siitonen S, Kemppainen E, et al. Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study. Crit Care. 2010;14(6):R207.
[24] Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet. 2003;361(9367):1447-55.
[25] Owusu L, Xu C, Chen H, Liu G, Zhang G, Zhang J, et al. Gamma-enolase predicts lung damage in severe acute pancreatitis-induced acute lung injury. J Mol Histol. 2018;49(4):347-356.
[26] Lei H, Minghao W, Xiaonan Y, Ping X, Ziqi L, Qing X. Acute lung injury in patients with severe acute pancreatitis. Turk J Gastroenterol. 2013;24:502-7.
[27] Samanta J, Singh S, Arora S, Muktesh G, Aggarwal A, Dhaka N, et al. Cytokine profile in prediction of acute lung injury in patients with acute pancreatitis. Pancreatology. 2018;18(8):878-884.
[28] Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO. Ameliroration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. AM J Surg. 1994;167(1):214-218.
[29] Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007;28(2):130-140.
[30] De Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995;27(5): 537-41.
[31] Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 1997;112(3)960-967.
[32] Chen ZQ, Tang YQ, Zhang Y, Jiang ZH, Mao EQ, Zou WG, et al. Adenoviral transfer of human interleukin-10 gene in lethal pancreatitis . World J Gastroenterol. 2004;10(20):3021-5.
[33] Jayanta Samanta, Sukhwinder Singh, Sunil Arora, Gaurav Muktesh, Ashuton Aggarwal, Narendra Dhaka, et al. Cytokine profile in prediction of acute lung injury in patients with acute pancreatitis. Pancreatology. 2018 ;18(8) :878-884.
[34] Nakamichil I, Habtezion A, Zhong B, Contag CH, Butcher EC, Om ary MB. Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction. J Clin Invest. 2005;115:3007-3014.
[35] Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, et al. Heme oxygenase-1 gene promoter polymorphism is associateed with the development of necrotizing acute pancreatitis. Pancreas. 2014;43(8) :1271-6.
[36] Tamion F, Richard V, Renet S, Thuillez C. Protective effects of heme-oxgenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10. J Trauma. 2006;61(5):1078-84.
[37] Zhu X, Fan WG, Li DP, Kung H, Lin MC. Heme oxygenase-1 system and gastronintestinal inflammation: a short review. World J Gastroenterol. 2011;17(38):4283-8.
[38] Liu B, Qian JM. Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injury. Int J Clin Exp Med. 2015;8(11):19867-73.
[39] Scharn CR, Collins AC, Nair VR, Stamm CE, Marciano DK, Graviss EA, et al. Heme oxygenase-1 regulates inflammation and mycobacterial survival in human macrophages during mycobacterium tuberculosis infection. J Immunol. 2016;196(11):4641-9.
[40] Liu ZM, Li N, Chen Y. Experimental study of the effect of Shenmai injection on post-cardiac arrest syndrome in rabbit. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25(11):664-8.